Neurology · Lebanon, NH
Neurology studies in Lebanon, NH
8 recruiting studies have a site in Lebanon.
8 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Dianthus Therapeutics
- Location
- Lebanon, NH + 29 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Kedrion S.p.A.
- Location
- Lebanon, NH + 4 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
UniQure Biopharma B.V.
- Location
- Lebanon, NH + 15 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
Neurona Therapeutics
- Location
- Lebanon, NH + 34 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteers
MCI Speech in Noise
Dartmouth-Hitchcock Medical Center
- Location
- Lebanon, NH
- Eligibility basics
- Ages 55–80
- RecruitingHealthy volunteers
ASSESS ALL ALS Study
St. Joseph's Hospital and Medical Center, Phoenix
- Location
- Lebanon, NH + 35 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
PREVENT ALL ALS Study
St. Joseph's Hospital and Medical Center, Phoenix
- Location
- Lebanon, NH + 30 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Human Intracranial Electrophysiology
Dartmouth-Hitchcock Medical Center
- Location
- Lebanon, NH
- Eligibility basics
- Ages 18+
Who these studies look for
Most require a confirmed diagnosis; memory studies often ask for a study partner who knows you well to attend some visits.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.